Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Takara Bio Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Takara Bio Inc. - Product Pipeline Review - 2014', provides an overview of the Takara Bio Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Takara Bio Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Takara Bio Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Takara Bio Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Takara Bio Inc.'s pipeline products Reasons to buy - Evaluate Takara Bio Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Takara Bio Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Takara Bio Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Takara Bio Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Takara Bio Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Takara Bio Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Takara Bio Inc. Snapshot 4 Takara Bio Inc. Overview 4 Key Information 4 Key Facts 4 Takara Bio Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Takara Bio Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Takara Bio Inc. - Pipeline Products Glance 11 Takara Bio Inc. - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Takara Bio Inc. - Drug Profiles 12 CD19-CAR Gene Therapy 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Cell Therapy to Activate MazF Gene for HIV-1 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 TBI-1201 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Takara Bio Inc. - Pipeline Analysis 18 Takara Bio Inc. - Pipeline Products by Target 18 Takara Bio Inc. - Pipeline Products by Route of Administration 19 Takara Bio Inc. - Pipeline Products by Molecule Type 20 Takara Bio Inc. - Pipeline Products by Mechanism of Action 21 Takara Bio Inc. - Recent Pipeline Updates 22 Takara Bio Inc. - Dormant Projects 23 Takara Bio Inc. - Discontinued Pipeline Products 24 Discontinued Pipeline Product Profiles 24 HSV-TK 24 Takara Bio Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Appendix 26 Methodology 26 Coverage 26 Secondary Research 26 Primary Research 26 Expert Panel Validation 26 Contact Us 27 Disclaimer 27
List of Tables Takara Bio Inc., Key Information 4 Takara Bio Inc., Key Facts 4 Takara Bio Inc. - Pipeline by Indication, 2014 6 Takara Bio Inc. - Pipeline by Stage of Development, 2014 7 Takara Bio Inc. - Monotherapy Products in Pipeline, 2014 8 Takara Bio Inc. - Partnered Products in Pipeline, 2014 9 Takara Bio Inc. - Partnered Products/ Combination Treatment Modalities, 2014 10 Takara Bio Inc. - Phase I, 2014 11 Takara Bio Inc. - Pipeline by Target, 2014 18 Takara Bio Inc. - Pipeline by Route of Administration, 2014 19 Takara Bio Inc. - Pipeline by Molecule Type, 2014 20 Takara Bio Inc. - Pipeline Products by Mechanism of Action, 2014 21 Takara Bio Inc. - Recent Pipeline Updates, 2014 22 Takara Bio Inc. - Dormant Developmental Projects,2014 23 Takara Bio Inc. - Discontinued Pipeline Products, 2014 24 Takara Bio Inc., Subsidiaries 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.